Tag: Diabetic retinopathy

In July 2014, the U.S. Food and Drug Administration (FDA) first approved EYLEA (aflibercept) for the treatment of diabetic macular edema (DME). This pivotal approval, based on robust clinical trial data, established EYLEA as a standard of care for a significant complication of diabetic eye disease.

While generally considered safe, post-marketing surveillance data shows that adverse events with calcium dobesilate can include fever (26%) and gastrointestinal disorders (12.5%) [1.4.6]. Understanding **what are the side effects of calcium Dobesilate?** is crucial for anyone prescribed this vasoprotective agent.

According to the CDC, diabetes is a leading cause of vision loss among working-age adults. In the effort to manage blood sugar, many ask, "**Does metformin help with blurry vision?**" The answer is complex, involving both temporary vision fluctuations and potential long-term protective effects.

Fenofibrate, a drug primarily known for treating high cholesterol and triglycerides, has been shown to reduce systemic inflammation markers like C-reactive protein (hsCRP) by nearly 50% in patients with metabolic syndrome. This powerful effect suggests that fenofibrate is an anti-inflammatory agent, exerting benefits beyond its standard lipid-modulating actions.

Susvimo was first FDA-approved in October 2021 for wet age-related macular degeneration, but a voluntary recall in 2022 due to manufacturing issues created a temporary hurdle. Today, following a successful relaunch in 2024, Susvimo is not only FDA-approved but also carries multiple indications for treating serious retinal conditions.

Following a single intravitreal injection of Avastin (bevacizumab), significant visual and anatomical improvements can be evident within weeks, with the effect often lasting up to two months in some patients with neovascular age-related macular degeneration (nAMD). However, the specific answer to **how long does Avastin work in the eye** depends on multiple factors, including the condition being treated, individual patient response, and the chosen treatment regimen. For sustained results, repeated injections are necessary.

According to the National Institutes of Health, fenofibrate significantly reduces plasma triglycerides and increases beneficial HDL cholesterol in adults with hypertriglyceridemia. These lipid-modifying actions are just part of the broader therapeutic profile that contributes to what are the good effects of fenofibrate.

The list price for Lucentis (ranibizumab), often misspelled as Accentrix, can be approximately $1,575 to $2,000 per injection [1.2.2, 1.2.4]. What is the cost of Accentrix injection and what factors determine the final price for patients needing this critical eye treatment?

Approximately 20 million Americans have some form of age-related macular degeneration (AMD), a condition often managed with intravitreal injections [1.9.1]. A common question for patients is, **how long do eye injections last?** The answer depends on the medication, the condition being treated, and individual patient response.

Originally approved for cancer treatment, Avastin (bevacizumab) has revolutionized ophthalmology as a widely used 'off-label' medication. When administered as an intraocular injection, **what is the use of Avastin in eye disease** is primarily to halt the growth of abnormal blood vessels that cause vision loss in various retinal conditions.